In islets of T2D patients, the increased DNA methylation of the insulin gene promoter (INS) at 4 CpG sites, correlates negatively with insulin mRNA levels and positively with glycated hemoglobin HbA(1c) levels, which reflect the cumulative blood glucose concentration (Yang et al., 2011). This evidence concerns the gene INS and type 2 diabetes mellitus.